Novel therapeutic targets in inflammatory bowel disease
Sign Up to like & getrecommendations! Published in 2019 at "Prescriber"
DOI: 10.1002/psb.1739
Abstract: SMAD7 antisense oligonucleotides and sphingosine‐1‐phosphate receptor modulators are new oral agents that are being investigated as potential treatments for inflammatory bowel disease (Crohn's disease and ulcerative colitis). This article reports on some of the clinical… read more here.
Keywords: bowel disease; inflammatory bowel; targets inflammatory; therapeutic targets ... See more keywords
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2019.00709
Abstract: Orexins [orexin-A (OXA) and orexin-B (OXB)] are two isoforms of neuropeptides produced by the hypothalamus. The main biological actions of orexins, focused on the central nervous system, are to control the sleep/wake process, appetite and… read more here.
Keywords: targets inflammatory; therapeutic targets; neurodegenerative diseases; inflammatory neurodegenerative ... See more keywords